Avanos Medical, Inc. (AVNS)
USD 16.18
(-4.94%)
USD 16.18
(-4.94%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.33 USD | -223.15% |
| 2022 | 1.08 USD | 730.77% |
| 2021 | 0.13 USD | 122.81% |
| 2020 | -0.57 USD | 40.63% |
| 2019 | -0.96 USD | -178.69% |
| 2018 | 1.22 USD | -27.81% |
| 2017 | 1.69 USD | 98.82% |
| 2016 | 0.85 USD | 109.29% |
| 2015 | -9.15 USD | -1677.59% |
| 2014 | 0.58 USD | -82.53% |
| 2013 | 3.32 USD | 1.22% |
| 2012 | 3.28 USD | 7.19% |
| 2011 | 3.06 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.04 USD | 301.03% |
| 2024 Q3 | 0.10 USD | 138.52% |
| 2024 Q1 | -0.02 USD | -108.48% |
| 2023 Q3 | -0.08 USD | 94.58% |
| 2023 Q2 | -1.46 USD | -13544.86% |
| 2023 Q1 | -0.01 USD | -102.97% |
| 2023 FY | - USD | -223.15% |
| 2023 Q4 | 0.23 USD | 390.77% |
| 2022 FY | - USD | 730.77% |
| 2022 Q4 | 0.36 USD | 5.88% |
| 2022 Q3 | 0.34 USD | 41.67% |
| 2022 Q2 | 0.24 USD | 100.0% |
| 2022 Q1 | 0.12 USD | -42.86% |
| 2021 Q2 | 0.79 USD | 593.75% |
| 2021 Q4 | 0.21 USD | 128.77% |
| 2021 FY | - USD | 122.81% |
| 2021 Q3 | -0.73 USD | -192.41% |
| 2021 Q1 | -0.16 USD | 83.84% |
| 2020 Q2 | -0.06 USD | -178.5% |
| 2020 Q1 | 0.08 USD | 161.54% |
| 2020 Q3 | 0.40 USD | 736.94% |
| 2020 FY | - USD | 40.63% |
| 2020 Q4 | -0.99 USD | -347.5% |
| 2019 Q4 | -0.13 USD | 45.83% |
| 2019 Q2 | -0.17 USD | 60.47% |
| 2019 Q3 | -0.24 USD | -41.18% |
| 2019 Q1 | -0.43 USD | -826.72% |
| 2019 FY | - USD | -178.69% |
| 2018 FY | - USD | -27.81% |
| 2018 Q4 | -0.05 USD | -151.56% |
| 2018 Q3 | 0.09 USD | -88.0% |
| 2018 Q2 | 0.75 USD | 74.42% |
| 2018 Q1 | 0.43 USD | -38.57% |
| 2017 Q3 | 0.35 USD | -5.41% |
| 2017 FY | - USD | 98.82% |
| 2017 Q4 | 0.70 USD | 100.0% |
| 2017 Q2 | 0.37 USD | 37.04% |
| 2017 Q1 | 0.27 USD | 28.57% |
| 2016 Q3 | 0.19 USD | 35.71% |
| 2016 FY | - USD | 109.29% |
| 2016 Q4 | 0.21 USD | 10.53% |
| 2016 Q2 | 0.14 USD | -53.33% |
| 2016 Q1 | 0.30 USD | -3.23% |
| 2015 FY | - USD | -1677.59% |
| 2015 Q4 | 0.31 USD | 103.07% |
| 2015 Q3 | -10.10 USD | -6041.18% |
| 2015 Q2 | 0.17 USD | -63.83% |
| 2015 Q1 | 0.47 USD | 1010.85% |
| 2014 Q1 | 0.89 USD | 3.49% |
| 2014 FY | - USD | -82.53% |
| 2014 Q2 | -0.10 USD | -111.24% |
| 2014 Q4 | -0.05 USD | 67.75% |
| 2014 Q3 | -0.16 USD | -60.0% |
| 2013 Q2 | 0.83 USD | 36.07% |
| 2013 Q4 | 0.86 USD | -16.5% |
| 2013 Q1 | 0.61 USD | 0.0% |
| 2013 FY | - USD | 1.22% |
| 2013 Q3 | 1.03 USD | 24.1% |
| 2012 FY | - USD | 7.19% |
| 2011 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Abbott Laboratories | 3.30 USD | 140.303% |
| Allurion Technologies Inc. | -2.31 USD | 42.424% |
| Artivion, Inc. | -0.75 USD | -77.333% |
| Butterfly Network, Inc. | -0.65 USD | -104.615% |
| Butterfly Network, Inc. | -0.65 USD | -104.615% |
| Bio-Rad Laboratories, Inc. | -21.82 USD | 93.905% |
| Boston Scientific Corporation | 1.08 USD | 223.148% |
| Perspective Therapeutics, Inc. | -0.10 USD | -1230.0% |
| CONMED Corporation | 2.10 USD | 163.333% |
| Edwards Lifesciences Corporation | 2.31 USD | 157.576% |
| Paragon 28, Inc. | -0.58 USD | -129.31% |
| Glaukos Corporation | -2.78 USD | 52.158% |
| Globus Medical, Inc. | 1.09 USD | 222.018% |
| Inspire Medical Systems, Inc. | -0.72 USD | -84.722% |
| Integer Holdings Corporation | 2.72 USD | 148.897% |
| Medtronic plc | 2.77 USD | 148.014% |
| Nevro Corp. | -2.56 USD | 48.047% |
| Owlet, Inc. | -4.53 USD | 70.64% |
| Penumbra, Inc. | 2.37 USD | 156.118% |
| Vicarious Surgical Inc. | -0.49 USD | -171.429% |
| Smith & Nephew plc | 0.60 USD | 321.667% |
| Sonendo, Inc. | -0.65 USD | -104.615% |
| STERIS plc | 3.83 USD | 134.726% |
| Stryker Corporation | 8.34 USD | 115.947% |
| Vapotherm, Inc. | -9.64 USD | 86.203% |
| Zimmer Biomet Holdings, Inc. | 4.91 USD | 127.088% |